CXL OPHTHALMICS, INC.
Sherborn, US · Founded 2022 · Delaware corporation · 1 known investors
Founders & leadership
MO
MARC ODRICHNamed on SEC filing
JT
JONATHAN TALAMONamed on SEC filing
EP
EDWARD PARSONSNamed on SEC filing
SM
SUSAN MACDONALDNamed on SEC filing
MW
MICHAEL WEBBNamed on SEC filing
Board
CL
CURT LABELLEBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$26.4M disclosed across 1 round · 2022
▶$26.4MraisedOct 2022 · 67 investors · PharmaceuticalsRule 506(b)
▶$26.4MraisedOct 2022 · 67 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- MARC ODRICHDirector
- JONATHAN TALAMODirector
- EDWARD PARSONSExecutive Officer
- SUSAN MACDONALDDirector
- CURT LABELLEDirector
- MICHAEL WEBBExecutive Officer, Director
- Offering amount
- $50.3M
- Amount sold
- $26.4M
- Sales commissions
- $1.7M
- Placement agents
- PIPER SANDLER & CO.
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are CXL OPHTHALMICS, INC.'s investors?
- CXL OPHTHALMICS, INC.'s investors include Tullis.
- How much funding has CXL OPHTHALMICS, INC. raised?
- CXL OPHTHALMICS, INC. has disclosed $26.4M raised across 1 round.
- Where is CXL OPHTHALMICS, INC. headquartered?
- CXL OPHTHALMICS, INC. is headquartered in Sherborn, US.